|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Peter Munk Cardiac Center, University Health Network, University of Toronto, 4N-464, Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, Canada M5G 2C4
(Email: vivek.rao@uhn.on.ca).
| The first 20% of the full text of this article appears below. |
The concept of prosthesis-patient mismatch (PPM) after aortic valve replacement (AVR) remains controversial today as long-term follow-up studies with adequate power to detect survival differences continue to provide discordant results [1–5]. Our previous study in 2000 demonstrated impaired survival after 7 years in patients who had PPM defined as an indexed effective orifice area (EOA) of < 0.85 cm2/m2 [1]. Due to the fact that we used the manufacturers reported "in-vitro" EOA, we liberalized our definition of PPM compared with the 0.75 cm2/m2 defined by Rahimtoolas [4] original description.
Similarly, Pibarot and colleagues [3] reported adverse hemodynamic effects of PPM in 392 patients undergoing stented AVR. Pibarot and colleagues [3] study revealed no survival differences, but important adverse effects of PPM on postoperative hemodynamics and symptom status. Subsequent studies by Pibarot and colleagues examined patients subjected to exercise
Related Article
Ann. Thorac. Surg. 2008 85: 1310-1317.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |